2393-21-7 Usage
Uses
Used in Pharmaceutical Production:
3-(2-AMINOETHYL)BENZOIC ACID is used as a precursor in the synthesis of various drugs, serving as a fundamental building block in the development of new pharmaceuticals.
Used in Antioxidant Applications:
3-(2-AMINOETHYL)BENZOIC ACID is used as an antioxidant agent, leveraging its potential to combat oxidative stress and protect biological systems from damage caused by reactive oxygen species.
Used in Analgesic Applications:
3-(2-AMINOETHYL)BENZOIC ACID is used as an analgesic agent, potentially providing pain relief through its interaction with pain signaling pathways.
Used in Materials Science:
3-(2-AMINOETHYL)BENZOIC ACID is used as a building block in the development of new materials, contributing to the advancement of material properties and applications.
Used in Bioactive Compound Synthesis:
3-(2-AMINOETHYL)BENZOIC ACID is used as a key component in the synthesis of bioactive compounds, facilitating the creation of molecules with specific biological activities for therapeutic and other applications.
Check Digit Verification of cas no
The CAS Registry Mumber 2393-21-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,3,9 and 3 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 2393-21:
(6*2)+(5*3)+(4*9)+(3*3)+(2*2)+(1*1)=77
77 % 10 = 7
So 2393-21-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H11NO2/c10-5-4-7-2-1-3-8(6-7)9(11)12/h1-3,6H,4-5,10H2,(H,11,12)
2393-21-7Relevant academic research and scientific papers
4,6-DISUBSTITUTED PYRIMIDINES AND THEIR USE AS PROTEIN KINASE INHIBITORS
-
Page/Page column 55, (2008/06/13)
The invention relates to novel pyrimidine derivatives of Formula (I), which are efficacious inhibitors of protein kinases, in particular of one or more isoforms of the protein kinase B/Akt.
Anti-thrombotic peptide and pseudopeptide derivatives
-
, (2008/06/13)
Disclosed are novel peptide and pseudopeptide derivatives and pharmaceutical compositions thereof that inhibit platelet aggregation and thrombus formation in mammalian blood.
